Info
Ownership

Michael Chambers - Insider Trading & Ownership

Location: 215 First Street, Cambridge, MA
Summary: The estimated net worth of Michael Chambers is at least $29.5M dollars as of March 11, 2025. Michael Chambers is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $29.5M.
Signature: /s/ Cristin Rothfuss, as Attorney-in-Fact for Michael Chambers
All Insider Reports: All Insider Reports

Ownership of Michael Chambers

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SRPT	Sarepta Therapeutics, Inc.	Director	$29.5M	+$4.96M	+20.2%	Mar 10, 2025

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Michael Chambers:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Award	+28.8%	$0		+2.38K	10.7K	3/10/2025	Direct
SRPT	Sarepta Therapeutics, Inc.	Stock Options (right to buy)	Award		$0	0.00	+4.79K	4.79K	3/10/2025	Direct
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Purchase	+15%	$4.96M	133.80	+37K	284K	8/16/2024	By Revocable Trust
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Award	+28.7%	$0	0.00	+1.85K	8.28K	3/1/2024	Direct
SRPT	Sarepta Therapeutics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+3.68K	3.68K	3/1/2024	Direct
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Purchase	+4.21%	$1.09M	109.47	+9.98K	247K	8/14/2023	By Revocable Trust
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Purchase	+11.1%	$2.56M	108.05	+23.7K	237K	8/11/2023	By Revocable Trust
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Purchase	+19.5%	$3.7M	106.15	+34.9K	213K	8/10/2023	By Revocable Trust
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Award	+31%	$0	0.00	+1.52K	6.43K	3/6/2023	Direct
SRPT	Sarepta Therapeutics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+3.26K	3.26K	3/6/2023	Direct
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Purchase	+111.8%	$5.96M	104.43	+57.1K	108K	9/14/2022	Direct
SRPT	Sarepta Therapeutics, Inc.	Convertible Senior Notes	Award		$20M			$20M	9/13/2022	By Revocable Trust
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Purchase	+940.7%	$5M	108.28	+46.2K	51.1K	8/19/2022	Direct
SRPT	Sarepta Therapeutics, Inc.	Common Stock	Award		$0	0.00	+4.91K	4.91K	6/2/2022	Direct
SRPT	Sarepta Therapeutics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+8.33K	8.33K	6/2/2022	Direct

Showing 1 to 15 of 15 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.